Report Detail
Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019
- RnM3839038 |
- 28 November, 2019 |
- Global |
- 113 Pages |
- GlobalData |
- Medical Devices & Consumables
Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019
Summary
GlobalData's Medical Devices sector report, “Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019" provides an overview of Cervical Cancer Diagnostic Tests currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cervical Cancer Diagnostic Tests pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Cervical Cancer Diagnostic Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Cervical Cancer Diagnostic Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Cervical Cancer Diagnostic Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
- 1.1 List of Tables 5
- 1.2 List of Figures 6
2 Introduction 7
- 2.1 Cervical Cancer Diagnostic Tests Overview 7
3 Products under Development 8
- 3.1 Cervical Cancer Diagnostic Tests - Pipeline Products by Stage of Development 8
- 3.2 Cervical Cancer Diagnostic Tests - Pipeline Products by Territory 9
- 3.3 Cervical Cancer Diagnostic Tests - Pipeline Products by Regulatory Path 10
- 3.4 Cervical Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date 11
- 3.5 Cervical Cancer Diagnostic Tests - Ongoing Clinical Trials 12
4 Cervical Cancer Diagnostic Tests - Pipeline Products under Development by Companies 13
- 4.1 Cervical Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development 13
- 4.2 Cervical Cancer Diagnostic Tests - Pipeline Products by Stage of Development 14
5 Cervical Cancer Diagnostic Tests Companies and Product Overview 15
- 5.1 Alere Inc Company Overview 15
- 5.1.1 Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 15
- 5.2 Augusta University Company Overview 16
- 5.2.1 Augusta University Pipeline Products & Ongoing Clinical Trials Overview 16
- 5.3 Becton Dickinson and Co Company Overview 17
- 5.3.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 17
- 5.4 Bio Techne Corp Company Overview 21
- 5.4.1 Bio Techne Corp Pipeline Products & Ongoing Clinical Trials Overview 21
- 5.5 BioAffinity Technologies, Inc. Company Overview 22
- 5.5.1 BioAffinity Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22
- 5.6 BioMark Diagnostics Inc Company Overview 23
- 5.6.1 BioMark Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 23
- 5.7 BioMark Technologies Inc Company Overview 24
- 5.7.1 BioMark Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 24
- 5.8 Cepheid Company Overview 25
- 5.8.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview 25
- 5.9 China Sky One Medical Inc Company Overview 26
- 5.9.1 China Sky One Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 26
- 5.10 Cytosystems Ltd Company Overview 27
- 5.10.1 Cytosystems Ltd Pipeline Products & Ongoing Clinical Trials Overview 27
- 5.11 Enzo Biochem Inc Company Overview 28
- 5.11.1 Enzo Biochem Inc Pipeline Products & Ongoing Clinical Trials Overview 28
- 5.12 Exact Sciences Corp Company Overview 29
- 5.12.1 Exact Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview 29
- 5.13 GenomicTree Inc Company Overview 30
- 5.13.1 GenomicTree Inc Pipeline Products & Ongoing Clinical Trials Overview 30
- 5.14 GRANT Life Sciences, Inc. Company Overview 32
- 5.14.1 GRANT Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
- 5.15 HLL Lifecare Ltd Company Overview 33
- 5.15.1 HLL Lifecare Ltd Pipeline Products & Ongoing Clinical Trials Overview 33
- 5.16 Louisville Bioscience, Inc. Company Overview 34
- 5.16.1 Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
- 5.17 MDNA Life Sciences Inc Company Overview 35
- 5.17.1 MDNA Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 35
- 5.18 MDxHealth SA Company Overview 36
- 5.18.1 MDxHealth SA Pipeline Products & Ongoing Clinical Trials Overview 36
- 5.19 Milagen Inc Company Overview 37
- 5.19.1 Milagen Inc Pipeline Products & Ongoing Clinical Trials Overview 37
- 5.20 Olympia Diagnostics Inc Company Overview 38
- 5.20.1 Olympia Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 38
- 5.21 Oncgnostics GmbH Company Overview 40
- 5.21.1 Oncgnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 40
- 5.22 ONCOVEDA Cancer Research Center Company Overview 41
- 5.22.1 ONCOVEDA Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview 41
- 5.23 Precision Biologics Inc Company Overview 42
- 5.23.1 Precision Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview 42
- 5.24 US Biomarkers Inc Company Overview 43
- 5.24.1 US Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview 43
- 5.25 XEPTAGEN SpA Company Overview 44
- 5.25.1 XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview 44
6 Cervical Cancer Diagnostic Tests - Recent Developments 45
- 6.1 Nov 05, 2019: BD announces results for 2019 fourth fiscal quarter and full year; provides fiscal 2020 guidance 45
- 6.2 Oct 30, 2019: Genomic Vision: Financial information for the third quarter of 2019 46
- 6.3 Oct 23, 2019: AdvaMed Statement on BD Sterilization Plant in Georgia 47
- 6.4 Oct 22, 2019: Quest Diagnostics reports third quarter 2019 financial results 48
- 6.5 Oct 03, 2019: Genomic Vision and PolyAn sign an agreement for the production and supply of Coverslips 48
- 6.6 Sep 26, 2019: BD announces leadership succession plan 49
- 6.7 Sep 24, 2019: Genomic Vision: First-half 2019 results 50
- 6.8 Sep 10, 2019: Quest Diagnostics names Manuel O. Méndez as new commercial leader 53
- 6.9 Aug 29, 2019: MDxHealth reports half year 2019 financial results and strategic update 54
- 6.10 Aug 26, 2019: New technique isolates placental cells for non-invasive genetic testing 56
- 6.11 Aug 20, 2019: Cancer Genetics reports second quarter 2019 financial results and provides strategic business update 57
- 6.12 Aug 06, 2019: BD announces results for 2019 third fiscal quarter; reaffirms fiscal 2019 guidance 58
7 Appendix 110
- 7.1 Methodology 110
- 7.2 About GlobalData 113
- 7.3 Contact Us 113
Summary:
Get latest Market Research Reports on Cervical Cancer Diagnostic Tests. Industry analysis & Market Report on Cervical Cancer Diagnostic Tests is a syndicated market report, published as Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019. It is complete Research Study and Industry Analysis of Cervical Cancer Diagnostic Tests market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
